Advertisement

Digestive Diseases and Sciences

, Volume 39, Issue 9, pp 1883–1884 | Cite as

Response by O. Bulbena

  • Oriol Bulbena
Letters To The Editor
  • 11 Downloads

Keywords

Public Health 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ: Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 38:730–739, 1993PubMedGoogle Scholar
  2. 2.
    Esplugues JV, Bulbena O, Escolar G, Navarro C, Esplugues J: Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol 109:145–151, 1985PubMedGoogle Scholar
  3. 3.
    Navarro C, Escolar G, Baños JE, Casanovas LI, Bulbena O: Effects of zinc acexamate on gastric mucosal production of prostaglandin E2 in normal and stressed rats. Prostaglandins Leukotrienes Essent Fatty Acids 33:75–80, 1988Google Scholar
  4. 4.
    Pfeiffer CJ, Bulbena O, Esplugues JV, Escolar G, Navarro C, Esplugues J: Anti-ulcer and membrane stabilizing actions of zinc acexamate. Arch Int Pharmacodyn Ther 285:148–157, 1987PubMedGoogle Scholar
  5. 5.
    Smith SM, Grisham MB, Manci EA, Granger DN, Kvietys PR: Gastric mucosal injury in the rat. Role of iron and xanthine oxidase. Gastroenterology 92:950–956, 1987PubMedGoogle Scholar
  6. 6.
    Escolar G, Navarro C, Galmés JL, Casanovas LI, Bulbena O: Zinc acexamate reduces gastric damage induced by platelet-activating factor. Prostaglandins Leukotrienes Essent Fatty Acids 38:49–53, 1989Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Oriol Bulbena
    • 1
  1. 1.Department of PharmacologyLab. Viñas, S.A.BarcelonaSpain

Personalised recommendations